4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001193125-25-319291
Options or other derivatives
- Director bought 2,285,714 shares at $17.49 ($39,977,138)
From the SEC's structured data for this filing
Trades in this filing
BAKER BROS. ADVISORS LP · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-11 | Purchase : show line 1 in the form $0.01 Prefunded Warrants | +190,523 | $17.49 | $3,332,247 | 2,335,469 | I |
| 2025-12-11 | Purchase : show line 2 in the form $0.01 Prefunded Warrants | +2,095,191 | $17.49 | $36,644,891 | 25,996,310 | I |
Loading xslF345X05/ownership.xml…